Sunshine Biopharma (SBFM) Gross Margin Growth (3y) (2021 - 2026)

Sunshine Biopharma (SBFM) Gross Margin Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 631.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 106.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -675.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 7,053.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 33.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -344.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -37,361.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -1,517.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 3,557.00
10 Sunshine Biopharma 10.94 Mn 4.03 Mn 2.18 Mn -1,039.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,039.00
Dec 31, 2025 -253.00
Sep 30, 2025 -1,783.00
Jun 30, 2025 -1,394.00
Mar 31, 2025 -2,053.00
Dec 31, 2024 424.00
Sep 30, 2024 -2,730.00
Jun 30, 2024 -3,966.00
Mar 31, 2024 -2,255.00
Dec 31, 2023 -2,921.00
Sep 30, 2023 -2,963.00
Jun 30, 2023 -3,081.00
Mar 31, 2023 -2,767.00
Dec 31, 2022 -2,251.00
Sep 30, 2022 2,272.00
Jun 30, 2022 -155.00
Mar 31, 2022 557.00
Mar 31, 2021 6,435.00